Assessment of genetically modified maize Bt11 x MIR162 x 1507 x GA21 and three subcombinations independently of their origin, for food and feed uses under Regulation (EC) No 1829/2003 (application EFSA-GMO-DE-2010-86).

In this opinion, the GMO Panel assessed the four-event stack maize Bt11 × MIR162 × 1507 × GA21 and three of its subcombinations, independently of their origin. The GMO Panel previously assessed the four single events and seven of their combinations and did not identify safety concerns. No new data on the single events or the seven subcombinations leading to modification of the original conclusions were identified. Based on the molecular, agronomic, phenotypic and compositional characteristics, the combination of the single events in the four-event stack maize did not give rise to food/feed safety issues. Based on the nutritional assessment of the compositional characteristics of maize Bt11 × MIR162 × 1507 × GA21, foods and feeds derived from the genetically modified (GM) maize are expected to have the same nutritional impact as those derived from non-GM maize varieties. In the case of accidental release of viable grains of maize Bt11 × MIR162 × 1507 × GA21 into the environment, this would not raise environmental safety concerns. The GMO Panel concludes that maize Bt11 × MIR162 × 1507 × GA21 is nutritionally equivalent to and as safe as its non-GM comparator in the context of the scope of this application. For the three subcombinations included in the scope, for which no experimental data were provided, the GMO Panel assessed the likelihood of interactions among the single events and concluded that their combinations would not raise safety concerns. These maize subcombinations are therefore expected to be as safe as the single events, the previously assessed subcombinations and the four-event stack maize. The post-market environmental monitoring plan and reporting intervals are in line with the intended uses of maize Bt11 × MIR162 × 1507 × GA21 and its subcombinations. A minority opinion expressed by a GMO Panel member is appended to this opinion.

[1]  C. Kohl,et al.  Humoral and cellular immune response in Wistar Han RCC rats fed two genetically modified maize MON810 varieties for 90 days (EU 7th Framework Programme project GRACE) , 2018, Archives of Toxicology.

[2]  A. Birch,et al.  Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005) , 2017, EFSA journal. European Food Safety Authority.

[3]  R. Binimelis,et al.  Teosinte in Europe – Searching for the Origin of a Novel Weed , 2017, Scientific Reports.

[4]  A. Birch,et al.  Risk assessment of information on the subcombination Bt11 × MIR162, related to the application of Syngenta (EFSA‐GMO‐DE‐2009‐66) for authorisation of food and feed containing, consisting and produced from genetically modified maize Bt11 × MIR162 × MIR604 × GA21 , 2017, EFSA journal. European Food Safety Authority.

[5]  G. Liew,et al.  Lutein and Zeaxanthin—Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection , 2017, Nutrients.

[6]  A. Birch,et al.  Scientific opinion on an application for renewal of authorisation for continued marketing of maize 1507 and derived food and feed submitted under Articles 11 and 23 of Regulation (EC) No 1829/2003 by Pioneer Overseas Corporation and Dow AgroSciences LLC , 2017, EFSA journal. European Food Safety Authority.

[7]  K. Pascher.  Spread of volunteer and feral maize plants in Central Europe: recent data from Austria , 2016, Environmental Sciences Europe.

[8]  R. Van Ree,et al.  Assessment of potential adjuvanticity of Cry proteins. , 2016, Regulatory toxicology and pharmacology : RTP.

[9]  M. Andreassen,et al.  Investigations of immunogenic, allergenic and adjuvant properties of Cry1Ab protein after intragastric exposure in a food allergy model in mice , 2016, BMC Immunology.

[10]  L. Moreno-Fierros,et al.  An overview of the safety and biological effects of Bacillus thuringiensis Cry toxins in mammals , 2016, Journal of applied toxicology : JAT.

[11]  A. Birch,et al.  Risk assessment of new sequencing data of GM maize event GA21 , 2015 .

[12]  Li Li,et al.  Carotenoid metabolism and regulation in horticultural crops , 2015, Horticulture Research.

[13]  J. Ward,et al.  The food and environmental safety of Bt crops , 2015, Front. Plant Sci..

[14]  A. Hilbeck,et al.  Transgene Expression and Bt Protein Content in Transgenic Bt Maize (MON810) under Optimal and Stressful Environmental Conditions , 2015, PloS one.

[15]  T. Rocheford,et al.  A Foundation for Provitamin A Biofortification of Maize: Genome-Wide Association and Genomic Prediction Models of Carotenoid Levels , 2014, Genetics.

[16]  Efsa Panel on Dietetic Products.  Scientific Opinion on Dietary Reference Values for vitamin A , 2015 .

[17]  Bruce Hammond,et al.  Toxicological evaluation of proteins introduced into food crops , 2013, Critical reviews in toxicology.

[18]  Rashida Ali,et al.  Dietary Sources of Lutein and Zeaxanthin Carotenoids and Their Role in Eye Health , 2013, Nutrients.

[19]  A. Chesson,et al.  Scientific Opinion updating the risk assessment conclusions and risk management recommendations on the genetically modified insect resistant maize 1507 , 2012 .

[20]  Efsa Panel on Dietetic Products.  Scientific Opinion on the substantiation of health claims related to lutein and maintenance of normal vision (ID 1603, 1604, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 , 2012 .

[21]  Antoine Messéan,et al.  Guidance on the Post-Market Environmental Monitoring (PMEM) ofgenetically modified plants , 2011 .

[22]  H. Kuiper,et al.  Guidance for risk assessment of food and feed from genetically modified plants , 2011 .

[23]  J. Wal,et al.  Immunological and Metabolomic Impacts of Administration of Cry1Ab Protein and MON 810 Maize in Mouse , 2011, PloS one.

[24]  Efsa Panel on Dietetic Products.  Scientific Opinion on the substantiation of health claims related to lutein and maintenance of vision (ID 1603, 1604, 1931) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 , 2010 .

[25]  B. Tinland,et al.  General Surveillance for Import and Processing: the EuropaBio approach , 2009, Journal für Verbraucherschutz und Lebensmittelsicherheit.

[26]  Enric Melé,et al.  Effect of volunteers on maize gene flow , 2009, Transgenic Research.

[27]  Elizabeth J Johnson,et al.  Xanthophyll (lutein, zeaxanthin) content in fruits, vegetables and corn and egg products , 2009 .

[28]  J. Wal,et al.  Comparative study of the adjuvanticity of Bacillus thuringiensis Cry1Ab protein and cholera toxin on allergic sensitisation and elicitation to peanut , 2008 .

[29]  Nathalie Colbach,et al.  Post-harvest gene escape and approaches for minimizing it , 2008 .

[30]  B. Tinland,et al.  General Surveillance: Roles and Responsibilities The Industry View , 2007, Journal für Verbraucherschutz und Lebensmittelsicherheit.

[31]  A. Shelton,et al.  Characterization of Chimeric Bacillus thuringiensis Vip3 Toxins , 2006, Applied and Environmental Microbiology.

[32]  J. Humphries,et al.  Distribution of lutein, zeaxanthin, and related geometrical isomers in fruit, vegetables, wheat, and pasta products. , 2003, Journal of agricultural and food chemistry.

[33]  Kevin R. Harwell.  United States Patent and Trademark Office , 2002 .

[34]  D. Negrotto,et al.  The use of phosphomannose-isomerase as a selectable marker to recover transgenic maize plants (Zea mays L.) via Agrobacterium transformation , 2000, Plant Cell Reports.

[35]  Vázquez,et al.  Bacillus thuringiensis Cry1Ac Protoxin is a Potent Systemic and Mucosal Adjuvant , 1999, Scandinavian journal of immunology.

[36]  N. Crickmore,et al.  Bacillus thuringiensis and Its Pesticidal Crystal Proteins , 1998, Microbiology and Molecular Biology Reviews.

[37]  M. Koziel,et al.  Vip3A, a novel Bacillus thuringiensis vegetative insecticidal protein with a wide spectrum of activities against lepidopteran insects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  K. Herrmann.  The Shikimate Pathway: Early Steps in the Biosynthesis of Aromatic Compounds. , 1995, The Plant cell.

[39]  A. Puhler,et al.  The Metabolites of the Herbicide L-Phosphinothricin (Glufosinate) (Identification, Stability, and Mobility in Transgenic, Herbicide-Resistant, and Untransformed Plants) , 1994, Plant physiology.

[40]  A. Pühler,et al.  Nucleotide sequence of the phosphinothricin N-acetyltransferase gene from Streptomyces viridochromogenes Tü494 and its expression in Nicotiana tabacum. , 1988, Gene.

[41]  R. Sydiskis,et al.  Genetic and Biochemical Studies on Mannose-Negative Mutants That Are Deficient in Phosphomannose Isomerase in Escherichia coli K-12 , 1967, Journal of bacteriology.

[42]  C. Then,et al.  Ninety-day oral toxicity studies on two genetically modified maize MON 810 varieties in Wistar Han RCC rats ( EU 7 th Framework Programme project GRACE ) “ , 2014 .

[43]  Antoine Messéan,et al.  Guidance on the environmental risk assessment of genetically modified plants , 2010 .

[44]  Joachim Schiemann,et al.  Scientific Opinion of the Panel on Genetically Modified Organisms , 2008 .

[45]  Thirty-Second Session.  JOINT FAO/WHO FOOD STANDARDS PROGRAMME , 2007 .

[46]  J. Adamczyk.  BREEDING AND GENETICS Genetic Basis for Variability of Cry1Ac Expression Among Commercial Transgenic Bacillus thuringiensis (Bt) Cotton Cultivars in the United States , 2004 .

[47]  Genetically modified organisms (GMOs): The significance of gene flow through pollen transfer , 2002 .

[48]  Consensus Document on Compositional Considerations for New Varieties of Maize ( Zea Mays ) : Key Food and Feed Nutrients , 2002 .

[49]  D. Stalker,et al.  Expression in Plants of a Bacterial Gene Coding for Glyphosate Resistance , 1987, Weed Science.